Alpha-synuclein is one of two other amyloidogenic key proteins, specifically, amyloid beta (Abeta) and tau, which play a major pathophysiological role in the three most common neurodegenerative diseases leading to dementia, namely Alzheimer’s disease (AD), DLB and Parkinson’s disease dementia (PDD). Here, MAPT is linked to dementia.